Sun Pharma to ramp up specialty portfolio in FY26
Sun Pharmaceutical Industries Ltd will continue to focus on its specialty products in FY26, which contributed to India's largest drugmaker's growth last fiscal. The company plans to invest an additional $100 million on the commercialization of its …